HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503 ; volume:9 ; number:1 ; day:4 ; month:3 ; year:2019 ; pages:1-16 ; date:12.2019
Scientific reports ; 9, Heft 1 (4.3.2019), 1-16, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Gorbatenko, Andrej
Søkilde, Rolf
Sorensen, Ester E.
Newie, Inga
Persson, Helena
Morancho, Beatriz
Arribas, Joaquin
Litman, Thomas
Rovira, Carlos
Pedersen, Stine Falsig
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39733-x
- URN
-
urn:nbn:de:101:1-2019032419164985742128
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gorbatenko, Andrej
- Søkilde, Rolf
- Sorensen, Ester E.
- Newie, Inga
- Persson, Helena
- Morancho, Beatriz
- Arribas, Joaquin
- Litman, Thomas
- Rovira, Carlos
- Pedersen, Stine Falsig
- SpringerLink (Online service)
Ähnliche Objekte (12)
Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
Influence of miR-221/222 on cardiomyocyte calcium handling and function
Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
Influence of miR-221/222 on cardiomyocyte calcium handling and function
Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
Influence of miR-221/222 on cardiomyocyte calcium handling and function
Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle